Sureda, Anna
Institut d'Investigació Biomédica de Bellvitge · Institut Català d'Oncologia · Universitat de Barcelona
7 papers on CoChatORCID 0000-0002-1238-6970
Most cited papers
- Verified
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Locke, F. L., Miklos, D. B., Jacobson, C. A., Perales, M.-A., Kersten, M.-J., Oluwole, O. O., Ghobadi, A., Rapoport, A. P., McGuirk, J., Pagel, J. M., et al. (2022) · New England Journal of Medicine
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 1,607
- Verified
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study
Kumar, S. K., Dimopoulos, M. A., Kastritis, E., Terpos, E., Nahi, H., Goldschmidt, H., Hillengass, J., Leleu, X., Beksac, M., Alsina, M., et al. (2017) · Leukemia
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 351
- Verified
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma
Rosiñol, L., Oriol, A., Rios, R., Sureda, A., Blanchard, M. J., Hernández, M. T., Martínez-Martínez, R., Moraleda, J. M., Jarque, I., Bargay, J., et al. (2019) · Blood
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 219
- Verified
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
Linton, K. M., Vitolo, U., Jurczak, W., Lugtenburg, P. J., Gyan, E., Sureda, A., Christensen, J. H., Hess, B., Tilly, H., Cordoba, R., et al. (2024) · The Lancet Haematology
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 171
- Verified
Role of hospital exemption in Europe: position paper from the Spanish advanced therapy Network (TERAV)
Sánchez-Guijo, F., Avendaño-Solá, C., Badimón, L., Bueren, J. A., Canals, J. M., Delgadillo, J., Delgado, J., Eguizábal, C., Fernández-Santos, M.-E., García-Olmo, D., et al. (2023) · Bone Marrow Transplantation
Biomedical Ethics and RegulationPharmaceutical Economics and Policy
Cited by 25
- Verified
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma
Falchi, L., Sureda, A., Leppä, S., Vermaat, J. S. P., Nijland, M., Christensen, J. H., de Vos, S., Holte, H., Merryman, R. W., Lugtenburg, P. J., et al. (2025) · Blood
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 15
- Verified
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study
Hurtado, L., Gonzalez Concepcion, M., Flix-Valle, A., Ruiz-Romeo, M., Gonzalez-Rodriguez, S., Peña, M., Paviglianiti, A., Pera Jambrina, M. A., Sureda, A., Ochoa-Arnedo, C., et al. (2024) · JMIR Formative Research
Telemedicine and Telehealth ImplementationMobile Health and mHealth Applications
Cited by 13
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free